Market Overview:
The global industrial hemp in medical market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth of this market is mainly attributed to the increasing demand for CBD oil and other cannabinoids for various medical applications. The non-cannabinoid group segment is expected to grow at a higher CAGR than the cannabinoid group segment during the forecast period. Among applications, hospitals are expected to hold the largest share of the global industrial hemp in medical market by 2030 owing to rising incidences of chronic diseases and growing awareness about CBD oil and its benefits among patients. Geographically, North America is estimated to account for the largest share of the global industrial hemp in medical market by 2030 followed by Europe and Asia Pacific.
Product Definition:
Industrial hemp is a variety of cannabis that is grown specifically for the industrial uses of its fibers, oils, and seeds. It is one of the fastest growing plants and was one of the first plants to be spun into usable fiber 10,000 years ago. Hemp can be used to make over 25,000 products including paper, textiles, clothing, biodegradable plastics, paint, insulation and biofuel.
Cannabinoid Groups:
Cannabidiol (CBD) is one of the many cannabinoids present in the hemp plant. Cannabinoids are naturally occurring substances found in both plants and animals. They are extracted from cannabis or hemp plants to create cannabidiol oil, which can be used for various medical purposes.
There are over 100 different cannabinoids that have been identified so far, but CBD is by far the most well known because of its wide range of therapeutic benefits.
Non-Cannabinoid Groups:
Non-cannabinoid (NCB) groups are a collection of over 100 different molecules found in both cannabis and hemp. These groups do not possess the same psychoactive effects as that of cannabinoids. The most common non-cannabinoid used in industrial hemp is starch, which can be used to make a variety of products such as paper, food additives, textiles and clothing materials among others.
Application Insights:
The global industrial hemp in medical market is segmented based on application as hospitals, clinics, and medical research centers. Hospitals held the largest share of the global market due to their ability to provide high-quality care and treatment in a cost-efficient manner. Due to regulations set by the U.S. Drug Enforcement Administration (DEA) for legalizing cultivation of cannabis for research purposes, many companies have shifted their focus towards developing industry standards for growing cannabis plants inside hospitals that are free from federal drug enforcement agents detection. This has led major players such as Phytotech Ltd., Cannevert Therapeutics Ltd., Radix Pharmaceuticals Inc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to presence of a large number of manufacturers and exporters coupled with favorable laws & regulations pertaining to industrial hemp cultivation and processing. Asia Pacific is anticipated to witness lucrative growth over the next eight years owing to increasing demand for natural products, such as cannabidiol (CBD) oil, which has therapeutic benefits without any intoxicating effects. Moreover, rising awareness about CBD oil among patients suffering from chronic diseases like cancer, diabetes, epilepsy, arthritis & rheumatism is further expected fuel regional growth during the forecast period. Europe accounted for more than 20% share in 2017 owing high product adoption rate especially in Germany and U.K., majorly due growing awareness regarding its health benefits across various applications including food additives/additives for cosmetics/lubricants/supplements etc.).
Growth Factors:
- Increasing demand for CBD oil and other hemp-based products for medical use
- Legalization of cannabis at the state level for medical use, which opens up new markets and opportunities
- Growing research on the benefits of CBD oil and other hemp-based products for various medical conditions
- The increasing popularity of holistic approaches to health and wellness, which has helped to drive demand for CBD oil and other hemp-based products
- The launch of new hemp-based products that target specific medical conditions
Scope Of The Report
Report Attributes
Report Details
Report Title
Industrial Hemp in Medical Market Research Report
By Type
Cannabinoid Groups, Non-Cannabinoid Groups
By Application
Hospitals, Clinics, Medical Research Centers
By Companies
Botanical Genetics, Boring Hemp, HempFlax, Isodiol, Tilray, HMI Group, Jinzhou Qiaopai Biotech, Yunnan Industrial Hemp, Shanghai Shunho New Materials Technology, CHENGZHI, Zhejiang CONBA Pharmaceutical, Dezhan Healthcare, Kunming Longjin Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Industrial Hemp in Medical Market Report Segments:
The global Industrial Hemp in Medical market is segmented on the basis of:
Types
Cannabinoid Groups, Non-Cannabinoid Groups
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Medical Research Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Botanical Genetics
- Boring Hemp
- HempFlax
- Isodiol
- Tilray
- HMI Group
- Jinzhou Qiaopai Biotech
- Yunnan Industrial Hemp
- Shanghai Shunho New Materials Technology
- CHENGZHI
- Zhejiang CONBA Pharmaceutical
- Dezhan Healthcare
- Kunming Longjin Pharmaceutical
Highlights of The Industrial Hemp in Medical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cannabinoid Groups
- Non-Cannabinoid Groups
- By Application:
- Hospitals
- Clinics
- Medical Research Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Industrial Hemp in Medical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Industrial hemp is a type of cannabis plant that has been bred specifically for industrial purposes, such as fiber and oil production. It is different from the marijuana plant, which is typically used for recreational purposes.
Some of the major players in the industrial hemp in medical market are Botanical Genetics, Boring Hemp, HempFlax, Isodiol, Tilray, HMI Group, Jinzhou Qiaopai Biotech, Yunnan Industrial Hemp, Shanghai Shunho New Materials Technology, CHENGZHI, Zhejiang CONBA Pharmaceutical, Dezhan Healthcare, Kunming Longjin Pharmaceutical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Industrial Hemp in Medical Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Industrial Hemp in Medical Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Industrial Hemp in Medical Market - Supply Chain
4.5. Global Industrial Hemp in Medical Market Forecast
4.5.1. Industrial Hemp in Medical Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Industrial Hemp in Medical Market Size (000 Units) and Y-o-Y Growth
4.5.3. Industrial Hemp in Medical Market Absolute $ Opportunity
5. Global Industrial Hemp in Medical Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Industrial Hemp in Medical Market Size and Volume Forecast by Type
5.3.1. Cannabinoid Groups
5.3.2. Non-Cannabinoid Groups
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Industrial Hemp in Medical Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Industrial Hemp in Medical Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Medical Research Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Industrial Hemp in Medical Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Industrial Hemp in Medical Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Industrial Hemp in Medical Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Industrial Hemp in Medical Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Industrial Hemp in Medical Demand Share Forecast, 2019-2026
9. North America Industrial Hemp in Medical Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Industrial Hemp in Medical Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Industrial Hemp in Medical Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Medical Research Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Industrial Hemp in Medical Market Size and Volume Forecast by Type
9.7.1. Cannabinoid Groups
9.7.2. Non-Cannabinoid Groups
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Industrial Hemp in Medical Demand Share Forecast, 2019-2026
10. Latin America Industrial Hemp in Medical Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Industrial Hemp in Medical Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Industrial Hemp in Medical Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Medical Research Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Industrial Hemp in Medical Market Size and Volume Forecast by Type
10.7.1. Cannabinoid Groups
10.7.2. Non-Cannabinoid Groups
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Industrial Hemp in Medical Demand Share Forecast, 2019-2026
11. Europe Industrial Hemp in Medical Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Industrial Hemp in Medical Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Industrial Hemp in Medical Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Medical Research Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Industrial Hemp in Medical Market Size and Volume Forecast by Type
11.7.1. Cannabinoid Groups
11.7.2. Non-Cannabinoid Groups
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Industrial Hemp in Medical Demand Share, 2019-2026
12. Asia Pacific Industrial Hemp in Medical Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Industrial Hemp in Medical Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Industrial Hemp in Medical Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Medical Research Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Industrial Hemp in Medical Market Size and Volume Forecast by Type
12.7.1. Cannabinoid Groups
12.7.2. Non-Cannabinoid Groups
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Industrial Hemp in Medical Demand Share, 2019-2026
13. Middle East & Africa Industrial Hemp in Medical Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Industrial Hemp in Medical Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Industrial Hemp in Medical Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Medical Research Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Industrial Hemp in Medical Market Size and Volume Forecast by Type
13.7.1. Cannabinoid Groups
13.7.2. Non-Cannabinoid Groups
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Industrial Hemp in Medical Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Industrial Hemp in Medical Market: Market Share Analysis
14.2. Industrial Hemp in Medical Distributors and Customers
14.3. Industrial Hemp in Medical Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Botanical Genetics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boring Hemp
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. HempFlax
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Isodiol
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Tilray
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. HMI Group
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Jinzhou Qiaopai Biotech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Yunnan Industrial Hemp
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Shanghai Shunho New Materials Technology
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. CHENGZHI
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Zhejiang CONBA Pharmaceutical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Dezhan Healthcare
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Kunming Longjin Pharmaceutical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook